Maggie Horner

Maggie Horner has over 30 years of work experience in the pharmaceutical industry. Maggie started their career as a Clinical Research Associate at Hoechst Roussel in 1989. Maggie then worked at Kendle as an Associate Director before joining Pfizer | ExecuPharm, Inc. where they held roles as a Director/Group Leader and Lead FSP Manager. In 2008, they became the Senior Director of Operations at Amicus Therapeutics. Maggie later worked at ICON as part of the Clinical Operations team. From 2013 to 2016, they served as the Vice President and General Manager of Cardiovascular, Metabolics, and Rare Diseases at inVentiv Health. Currently, they are the Executive Director of Clinical Operations at Esperion.

Maggie Horner completed their education in a chronological manner. In 1981, they enrolled at Rutgers University, where they pursued a Bachelor of Arts degree in Microbiology, with a specialization in General Microbiology. Maggie successfully completed their studies in 1985.

After a gap of many years, in 2003, Maggie attended American InterContinental University to pursue a Master of Business Administration (MBA) with a focus on Global Management. Their MBA studies lasted for the duration of one year.

In addition to these educational qualifications, Maggie also holds a certification in MBA. However, specific details such as the institution from where they obtained this certification, as well as the month and year of completion, are not provided.